Valeant Pharmaceuticals has forked over $28 million to acquire EMO-FARM, a Poland-based dermatology company. Valeant says EMO-FARM is an expert in topical products, and also brings with it a portfolio of marketed and investigational products. As part of the transaction, Valeant will also acquire a 13,000 square foot manufacturing plant completed earlier this year that specializes in gels, creams and ointments. Valeant release